| Title |
Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species
|
|---|---|
| Published in |
BMC Infectious Diseases, April 2005
|
| DOI | 10.1186/1471-2334-5-22 |
| Pubmed ID | |
| Authors |
Ming-Fang Cheng, Yun-Liang Yang, Tzy-Jyun Yao, Chin-Yu Lin, Jih-Shin Liu, Ran-Bin Tang, Kwok-Woon Yu, Yu-Hua Fan, Kai-Sheng Hsieh, Monto Ho, Hsiu-Jung Lo |
| Abstract |
Invasive fungal infections, such as candidemia, caused by Candida species have been increasing. Candidemia is not only associated with a high mortality (30% to 40%) but also extends the length of hospital stay and increases the costs of medical care. Sepsis caused by Candida species is clinically indistinguishable from bacterial infections. Although, the clinical presentations of the patients with candidemia caused by Candida albicans and non-albicans Candida species (NAC) are indistinguishable, the susceptibilities to antifungal agents of these species are different. In this study, we attempted to identify the risk factors for candidemia caused by C. albicans and NAC in the hope that this may guide initial empiric therapy. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| Paraguay | 1 | <1% |
| Peru | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 133 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 19% |
| Student > Bachelor | 20 | 15% |
| Student > Ph. D. Student | 15 | 11% |
| Researcher | 13 | 9% |
| Student > Postgraduate | 12 | 9% |
| Other | 20 | 15% |
| Unknown | 31 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 30% |
| Agricultural and Biological Sciences | 21 | 15% |
| Biochemistry, Genetics and Molecular Biology | 12 | 9% |
| Immunology and Microbiology | 11 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Other | 8 | 6% |
| Unknown | 36 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2019.
All research outputs
#2,450,205
of 22,712,476 outputs
Outputs from BMC Infectious Diseases
#735
of 7,657 outputs
Outputs of similar age
#4,210
of 59,558 outputs
Outputs of similar age from BMC Infectious Diseases
#2
of 12 outputs
Altmetric has tracked 22,712,476 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,657 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,558 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.